Skip to main content
SpringerLink
Log in

Management of thyroglobulin-positive, body scan-negative thyroid cancer patients: Evidence for the utility of I-131 therapy

  • Opinion
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Pacini F., Lippi F., Formica N., Elisei R., Anelli S., Ceccarelli C., Pinchera A. Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels. J. Nucl. Med. 1987, 28: 1888–1891.

    CAS  PubMed  Google Scholar 

  2. Schlumberger M., Arcangioli O., Piekarski J.D., Tubiana M., Parmentier C. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest x-rays. J. Nucl. Med. 1988, 29: 1790–1804.

    CAS  PubMed  Google Scholar 

  3. Pineda J.D., Lee T., Ain K., Reynolds J.C., Robbins J. Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. J. Clin. Endocrinol. Metab. 1995, 80: 1488–1492.

    CAS  PubMed  Google Scholar 

  4. Spencer C.A., Wang C.-C. Thyoglobulin measurements: Techniques, clinical benefits and pitfalls. Endocrinol. Metab. Clin. North Am. 1995, 24: 841–863.

    CAS  PubMed  Google Scholar 

  5. Reynolds J.C., Robbins J. The changing role of radioiodine in the management of differentiated thyroid cancer. Seminars in Nucl. Med. 1997, 27: 152–164.

    Article  CAS  Google Scholar 

  6. Benua R.S., Cicalle N.R., Sonenberg M., Rauzon R.W. The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer. Am. J. Roentgenol. 1962, 87: 171–182

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Genetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA

    J. Robbins M.D.

Authors
  1. J. Robbins M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Robbins, J. Management of thyroglobulin-positive, body scan-negative thyroid cancer patients: Evidence for the utility of I-131 therapy. J Endocrinol Invest 22, 808–810 (1999). https://doi.org/10.1007/BF03343649

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03343649

Keywords

Search

Navigation